“Roflumilast Cream 0.15% in Patients With Atopic Dermatitis: Individual Patient Response from the Pooled INTEGUMENT-1 and INTEGUMENT-2 Phase 3 Trials”. SKIN The Journal of Cutaneous Medicine, vol. 8, no. 2, Mar. 2024, p. s372, https://doi.org/10.25251/skin.8.supp.372.